TD Cowen Downgrades Rocket Pharmaceuticals (RCKT) to Hold following patient death
Tweet Send to a Friend
TD Cowen analyst Tyler Van Buren downgraded Rocket Pharmaceuticals (NASDAQ: RCKT) from Buy to Hold.The analyst commented, "The patient death ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
